# Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril

> **NCT02654678** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Ethicare GmbH** · enrollment: 100 (estimated)

## Conditions studied

- Heart Failure
- Dilated Cardiomyopathy
- Congenital Heart Disease

## Interventions

- **DRUG:** Enalapril Orodispersible Minitablet

## Key facts

- **NCT ID:** NCT02654678
- **Lead sponsor:** Ethicare GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2016-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02654678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02654678, "Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02654678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*